期刊文献+

系统性硬化病与心血管疾病 被引量:3

Systemic Sclerosis and Cardiovascular Disease
下载PDF
导出
摘要 系统性硬化病是一种以弥漫性血管病变及皮肤、内脏纤维化为主要特征的结缔组织疾病。本病少见,起病隐匿,累及心脏时常被其特有的心脏外表现所掩盖。但是,正确的运用一些辅助检查,我们可以发现几乎100%系统性硬化的病人合并有不同程度的心血管系统受累,且当患者出现心脏受累的临床表现后通常预后不良。因此如何早期发现系统性硬化病累及心脏尤为重要。 Systemic sclerosis (SSc) is a connective tissue disease characterized by diffused vascular lesions and fibrosis of the skin and major organs including heart, lung and kidney etc. Cardiac involvement, including primary myocardial involvement, is very common in SSc although it is often clinically asymptomatic. When sensitive measures of assessment are used, it has been estimated to occur in up to 100% of SSc patients. Cardiac involvement can be manifested by myocardial disease, conduction abnormalities and pericardial disease etc. Additionally, SSc renal crisis and pulmonary hypertension lead to significant cardiac dysfunction secondary to damage in the kidney and lung. Clinically evident cardiac involvement is recognized to be a poor prognostic factor; thus preclinical identification is highly encouraged.
出处 《中国分子心脏病学杂志》 CAS 2010年第4期254-256,共3页 Molecular Cardiology of China
关键词 系统性硬化病 心脏受累 治疗 Systemic sclerosis Cardiac involvement Treatment
  • 相关文献

参考文献22

  • 1Scalapino K, Arkachaisri T, Lucas M, et al. Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease. JRheumatol, 2006, 33: 1004- 1013.
  • 2Yannick Allanorea, Christophe Meuneb. Systemic sclerosis and cardiac dysfunction: evolving concepts and diagnostic methodologies. Curr Opin Rheumatol, 2008, 20: 697-702.
  • 3Czirja k L, Kuma novics G, Varju C, et al. Survival and causes of death in 366 Hungarian patients with systemic sclerosis. Ann Rheum, 2008, 67: 59-63.
  • 4Clements P. Clinical aspects of localized and systemic sclerosis. Curr Opin Rheumatol, 1992, 4: 843.
  • 5Kahan,Y.Allanore. Primary myocardial involvement in systemic sclerosis. Rheumatology, 2006, 45: 1514-t517.
  • 6Deswal A, Follansbee WE Cardiac involvement in scleroderma. Rheum Dis Clin North Am, 1996, 22: 841.
  • 7Paradiso M, Di Franco M, Musca A, et al. Ventricular late potentials in systemic sclerosis: relationship with skin involvement.. J Rheumatol, 2002,29:1388.
  • 8Highland KB, Garin MC, Brown KK. The spectrum of scleroderma lung disease. Semin Respir Crit Care Med, 2007, 28:418-429.
  • 9Steen VD, Scleroderma renal crisis, Rheum Dis Clin North Am, 2003, 29: 315-333.
  • 10M. Matucci-Cerinicl,V. Steen, P. Nash, et al. Hachulla The complexity of managing systemic sclerosis: screening and diagnosis. Rheumatology, 2009, 48: 38-313.

同被引文献14

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部